Hafsa, H.; Zamir, A.; Rasool, M.F.; Imran, I.; Saeed, H.; Ahmad, T.; Alsanea, S.; Alshamrani, A.A.; Alruwaili, A.H.; Alqahtani, F.
Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations. Pharmaceutics 2022, 14, 2362.
https://doi.org/10.3390/pharmaceutics14112362
AMA Style
Hafsa H, Zamir A, Rasool MF, Imran I, Saeed H, Ahmad T, Alsanea S, Alshamrani AA, Alruwaili AH, Alqahtani F.
Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations. Pharmaceutics. 2022; 14(11):2362.
https://doi.org/10.3390/pharmaceutics14112362
Chicago/Turabian Style
Hafsa, Hafsa, Ammara Zamir, Muhammad Fawad Rasool, Imran Imran, Hamid Saeed, Tanveer Ahmad, Sary Alsanea, Ali A. Alshamrani, Abdullah H. Alruwaili, and Faleh Alqahtani.
2022. "Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations" Pharmaceutics 14, no. 11: 2362.
https://doi.org/10.3390/pharmaceutics14112362
APA Style
Hafsa, H., Zamir, A., Rasool, M. F., Imran, I., Saeed, H., Ahmad, T., Alsanea, S., Alshamrani, A. A., Alruwaili, A. H., & Alqahtani, F.
(2022). Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations. Pharmaceutics, 14(11), 2362.
https://doi.org/10.3390/pharmaceutics14112362